AKT1 and cardiac hypertrophy: Isorhamnetin and its derivatives demonstrate ROS-scavenging capacity while their antihypertensive effects are associated with ACE inhibition and blockade of the PI3K/AKT signaling pathway, preventing cardiac hypertrophy and fibrosis [45].